The Department of Health and Human Services (HHS) finalized a rule that sets penalties, including cuts to Medicare payments, ...

Senators Dick Durbin of Illinois and Mike Braun of Indiana recently introduced bipartisan legislation aimed at closing ...

The United States Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) recently ...

Policy & Medicine offers a daily look at legal, regulatory, and compliance issues affecting the pharmaceutical and device industry. Since its inception in 2008, Policy & Medicine has become one of the ...

A federal appeals court recently preserved the Affordable Care Act’s popular mandate that private insurance cover preventive services at no cost to patients. However, the U.S. Court of Appeals for the ...

Guardant Health, Inc., a precision oncology company in California, reached a settlement with the United States Department of ...

Sign up here to get the latest news and updates delivered directly to your inbox.

Guardant Health, Inc., a precision oncology company in California, reached a settlement with the United States Department of Justice (DOJ) to resolve allegations that it knowingly violated the False ...

In the ever-evolving world of oncology, access to effective treatments and their affordability is a constant concern. In ...

Thomas Sullivan is Editor of Policy and Medicine, Senior Vice President at Clinical Education Alliance (CEA) a leading continuing education provider. Founder and director of CME Coalition a lobbying ...

Through daily website posts that are also sent via daily email, Policy and Medicine presents timely news, mixed with consistent opinion and insight for the pharmaceutical and device industries and CME ...

The U.S. Food and Drug Administration (FDA) issued the revised draft guidance, “Addressing Misinformation About Medical Devices and Prescription Drugs,” which clarifies how firms can address ...